Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Degenerative Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02515942
What this trial is testing

CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Alcon Research 114
Not applicableStudy completedNCT02540369
What this trial is testing

To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

Who this might be right for
Wet Macular Degeneration
Bayer 2,150
Not applicableStudy completedNCT04014673
What this trial is testing

Natural History Characterization in Symptomatic and Asymptomatic Progranuline Gene Mutation Carriers

Who this might be right for
Frontotemporal Lobar Degeneration
Assistance Publique - Hôpitaux de Paris 78
Not applicableWithdrawnNCT03162666
What this trial is testing

Patient Outcomes Using an Expandable Spacer

Who this might be right for
Degenerative Disc Disease
Globus Medical Inc
Not applicableStudy completedNCT05999266
What this trial is testing

The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisKnee Pain ChronicMuscle Loss+1 more
Sisli Hamidiye Etfal Training and Research Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT04684394
What this trial is testing

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal DiseaseRetinal Degeneration+1 more
Gemini Therapeutics, Inc. 50
Not applicableStudy completedNCT02868086
What this trial is testing

The Impact of Two Strategies in the Monitoring of Exudative ARMD on the Visual Acuity (by OCT B Scan or OCT Angiography)

Who this might be right for
Age-related Macular Degeneration
Fondation Ophtalmologique Adolphe de Rothschild 68
Not applicableStudy completedNCT01413061
What this trial is testing

Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft

Who this might be right for
Degenerative OsteoarthritisPost-traumatic; ArthrosisRheumatoid Arthritis & Other Inflammatory Polyarthropathies+1 more
AlloSource 140
Post-approval studies (Phase 4)Ended earlyNCT01319188
What this trial is testing

Ranibizumab and the Risk of Arterial Thromboembolic Events

Who this might be right for
Age-related Macular DegenerationCoronary Artery DiseaseCerebrovascular Disorders
Ural State Medical University 380
Testing effectiveness (Phase 2)Study completedNCT02914639
What this trial is testing

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
OcuTerra Therapeutics, Inc. 44
Early research (Phase 1)UnknownNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Large-scale testing (Phase 3)WithdrawnNCT02229175
What this trial is testing

Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
University of California, San Francisco
Early research (Phase 1)Study completedNCT04014777
What this trial is testing

Study of NGM621 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy
NGM Biopharmaceuticals, Inc 15
Large-scale testing (Phase 3)UnknownNCT01277172
What this trial is testing

TREatment of degeNerative and Neoplastic Diseases With Rituximab

Who this might be right for
Diffuse Large B Cell Lymphoma
Probiomed S.A. de C.V. 54
Testing effectiveness (Phase 2)Study completedNCT07010575
What this trial is testing

Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride

Who this might be right for
Wilson's Disease
Orphalan 10
Not applicableStudy completedNCT04008771
What this trial is testing

Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

Who this might be right for
Retinitis Pigmentosa
2C Tech Corp 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06579287
What this trial is testing

SHJ002 Sterile Ophthalmic Solution for Myopia Control

Who this might be right for
Myopia, Progressive
Sunhawk Vision Biotech, Inc. 140
Post-approval studies (Phase 4)Study completedNCT00165893
What this trial is testing

Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease

Who this might be right for
Degenerative Disc Disease
Emory University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06615505
What this trial is testing

ASCEND: A Clinical Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs

Who this might be right for
Degenerative Disc DiseaseDisc DegenerationLumbar Discogenic Pain
VIVEX Biologics, Inc. 121
Early research (Phase 1)Study completedNCT02076919
What this trial is testing

First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Alcon Research 110
Next Page